/PRNewswire/ Hurdle, an innovative digital mental health company, today announced the publication of a white paper on Black mental health before and after.
Philly CEAL team receives NIH grant to extend COVID-19 outreach
José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH s Community Engagement Alliance (CEAL) Against COVID-19 Disparities.
The Philly CEAL team was awarded $1.4 million from the NIH with additional support from Penn Nursing and The University of Pennsylvania, bringing the total for the alliance to $1.53 million.
The toll of the pandemic among racial/ethnic populations in Philadelphia cannot be understated. Alongside the stark morbidity and mortality COVID-19 estimates reported by the city, racial/ethnic minorities in Philadelphia have also been most likely to experience job loss, income reduction, and decreased access to social resources.
Credit: Penn Nursing
PHILADELPHIA (May 19, 2021) - José A. Bauermeister, PhD, and Antonia M. Villarruel, PhD, are leading one of 10 new research teams from across the country that received National Institutes of Health (NIH) grants totaling $14 million to extend the reach of the NIH s Community Engagement Alliance (CEAL) Against COVID-19 Disparities. The Philly CEAL team was awarded $1.4 million from the NIH with additional support from Penn Nursing and The University of Pennsylvania, bringing the total for the alliance to $1.53 million. The toll of the pandemic among racial/ethnic populations in Philadelphia cannot be understated. Alongside the stark morbidity and mortality COVID-19 estimates reported by the city, racial/ethnic minorities in Philadelphia have also been most likely to experience job loss, income reduction, and decreased access to social resources, said Bauermeister, the Albert M. Greenfield Professor of Human Relations and Chair of the Department of Family & Co
E-Mail
DALLAS, May 17, 2021 Detecting a critical heart defect before birth (congenital heart defects) is less likely when a mother lives in a rural area, lives in a neighborhood with low socioeconomic status or is Hispanic, according to new research published today in the American Heart Association s flagship journal Circulation.
Diagnosing a heart defect before birth reduces infant death rates, increases access to prompt medical treatment, improves neurodevelopmental outcomes and decreases the risk of brain injury for the infant after birth. The benefits of prenatal diagnosis for heart defects have been recognized for years, yet prenatal detection occurs in less than 60% of congenital heart disease cases in many U.S. regions, said the study s first author Anita Krishnan, M.D., an associate professor of pediatrics and associate director of echocardiography at Children s National Hospital in Washington, D.C.
Debra Furr-Holden, associate dean for Public Health Integration at Michigan State University, answers questions about resuming the Johnson & Johnson vaccine. She is also the director of the Flint Center for Health Equity Solutions, funded by the National Institute on Minority Health and Health Disparities; and she was appointed by Gov. Gretchen Whitmer to be a member of the Michigan Coronavirus Task Force on Racial Disparities.
The vaccine is much safer than contracting COVID-19. To put this in perspective, out of 7-million doses of the J&J vaccine administered, less than 20 people developed clots. As an epidemiologist who studies health risks, I agree with medical colleagues across the world who agree the vaccine has proven to be safe and the clots that have occurred are extremely rare. We monitor adverse reactions on an ongoing basis from all of the currently available vaccines to make sure we understand and can minimize any risks.